The mentioned products may not have Marketing Authorization in all countries. Please refer to the locally approved PI

Please click here to see prescribing information for OMNIPAQUE™ (iohexol)

Please click here to see prescribing information for VISIPAQUE™ (iodixanol)

Reporting Adverse Events

GE HealthCare has a legal and ethical responsibility to protect the public health and therefore we ensure safety and efficiency for our products. In order to do so, we collect reports about suspected adverse events that the patients experience during or after they are exposed to our products.

We also collect information about special situations (such as exposure during pregnancy, overdose, etc. ) as well as customer complaints and other views from customers about our products.

To report a suspected adverse event/special situation, customer complaint or just to share your views about our products, please contact: [email protected]

 Privacy Policy | Terms And Conditions | Update Profile | Contact Us | Unsubscribe

 

© 2025 GE HealthCare
Omnipaque™ and Visipaque™ are a trademark of GE HealthCare.
GE is a trademark of General Electric Company used under trademark license.
06-2025 | JB00152XM